Gliadel intracerebral implantation agent 7.7 mg is manufactured by Eisai with YJ code 4219700X1020, standardized at 7.7mg per piece. This implant delivers carmustine directly into the brain after tumor resection and is indicated as an adjunct to surgery and radiation for newly diagnosed high-grade malignant glioma, and as an adjunct to surgery for recurrent glioblastoma multiforme.
Gliadel intracerebral implantation agent 7.7 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →